OraSure Technologies | OSUR - Gross Profit On Sales


OraSure Technologies reported $11.34M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 44M Mar/2026
AngioDynamics USD 44.78M 2.93M Sep/2025
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Bio Techne USD 208.29M 17.01M Mar/2026
Bio-Rad Laboratories USD 345.2M 1.8M Dec/2025
Bruker USD 379.8M 69.4M Mar/2026
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 427M 16M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
Illumina USD 721M 38M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quidel USD -91.8M 366.6M Mar/2026
Repligen USD 108.28M 4.45M Mar/2026
Revvity USD 387.66M 34M Mar/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Trinity Biotech USD 6.47M 1.59M Sep/2025
Waters USD 542M 15.42M Mar/2026